Wallace Owen B.

CIK 00017788432 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001778843

Recent Transactions

27 trades

Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-01-02+119,000→ 119,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-01-03+135,000→ 135,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-03-01+117,450→ 117,450 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-06-23+113,298→ 113,298 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2021-04-12+387,069→ 387,069 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-09-14$7.84/sh+6,350→ 133,438 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-09-14−6,350→ 75,592 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-07-08$7.84/sh+2,951→ 130,039 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-07-08−2,951→ 81,942 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-07-08$20.00/sh−2,951→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-06-30−141→ 84,893 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-30$7.84/sh+141→ 127,229 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-06-30$20.00/sh−141→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-05-28−2,232→ 85,034 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-28$20.00/sh−2,232→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-28$7.84/sh+2,232→ 129,320 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-05-27−448→ 87,266 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-27$20.00/sh−448→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-27$7.84/sh+448→ 127,536 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-26$7.84/sh+412→ 127,500 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-05-26−412→ 87,714 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-05-26$20.00/sh−412→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-02-19−6,088→ 88,126 total
Sale
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-02-19$20.00/sh−6,088→ 127,088 total
Exercise/Conversion
Fulcrum Therapeutics, Inc.$FULC
Common Stock
2020-02-19$7.84/sh+6,088→ 133,176 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2020-01-23+58,900→ 58,900 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2019-07-18+44,493→ 44,493 total

Companies

Recent Filings

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov